Anaheim Clinical Trials (ACT) Opens Quarter Million Dollar Expansion
Anaheim, California (June 23, 2014) -- Anaheim Clinical Trials (ACT), an adult and pediatric Phase I through Phase IV clinical research center with full-service CRO capabilities announced that it has opened its $250K expansion. The expansion includes two (2) large boardrooms and six (6) individual monitoring offices. The additional space is dedicated to serve Clinical Research monitors while accommodating up to eight (8) separate Pharmaceutical companies daily. Up to two monitors can comfortably work in each of the six spacious and sound proof individual monitoring offices. In addition, two large board rooms are available for study initiations. Regulatory and Data Entry Departments are conveniently located adjacent to the monitoring rooms to promote convenient access and speed communication between monitors and professional staff to address study questions or queries. Also, fire-proof cabinets have been installed in the area to protect all essential study documents, such as charts and medical data. “Anaheim Clinical Trials recognizes and appreciates the work of the Clinical Research Associates (CRAs) who monitor our studies. Our goal was to facilitate their visits and make them as comfortable as we can,” said Patrick McLaughlin, Executive Director.
About Anaheim Clinical Trials:
Anaheim Clinical Trials (ACT) is an adult and pediatric Phase I-IV clinical research center, located in southern California (Anaheim). In addition to healthy volunteers, ACT has been particularly successful in enrolling special patient populations, such as renal- and hepatic-impaired patients, and Japanese subjects for ethno-bridging trials. Our certified Principal Investigators have the expertise and interest in a wide variety of therapeutic areas, including GI, pain, metabolic/inflammation, infectious diseases, and respiratory. ACT has been recognized by our customers for excellent quality research, timeliness, high patient enrollment, and ease of doing business. For more information, please visit our website at www.act-trials.com.
Anaheim Clinical Trials Contact
Linda Gundaker, MBA, MT(ASCP)
Executive Director of Business Development
Phone: (610) 937-2006
lgundaker@act-trials.com
Help employers find you! Check out all the jobs and post your resume.
